Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Other Non Operating Income (2016 - 2025)

CorMedix (CRMD) has disclosed Other Non Operating Income for 12 consecutive years, with $75195.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 123.95% to $75195.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$51999.0 through Dec 2025, down 134.98% year-over-year, with the annual reading at -$52000.0 for FY2025, 127.96% down from the prior year.
  • Other Non Operating Income hit $75195.0 in Q4 2025 for CorMedix, up from -$72727.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $500000.0 in Q2 2024 to a low of -$314000.0 in Q4 2024.
  • Historically, Other Non Operating Income has averaged $10201.2 across 5 years, with a median of -$6420.0 in 2021.
  • Biggest five-year swings in Other Non Operating Income: soared 3840.28% in 2024 and later tumbled 852.4% in 2025.
  • Year by year, Other Non Operating Income stood at -$11066.0 in 2021, then surged by 150.13% to $5547.0 in 2022, then crashed by 626.39% to -$29199.0 in 2023, then plummeted by 975.38% to -$314000.0 in 2024, then surged by 123.95% to $75195.0 in 2025.
  • Business Quant data shows Other Non Operating Income for CRMD at $75195.0 in Q4 2025, -$72727.0 in Q3 2025, and -$16295.0 in Q2 2025.